Centaurus Financial Inc. Takes Position in Cigna Group $CI

Centaurus Financial Inc. acquired a new position in Cigna Group (NYSE:CI) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,975 shares of the health services provider’s stock, valued at approximately $544,000.

Several other large investors have also recently bought and sold shares of the stock. BlackRock Inc. increased its stake in Cigna Group by 3.7% during the second quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock valued at $6,461,457,000 after acquiring an additional 840,098 shares during the period. State Street Corp lifted its position in shares of Cigna Group by 1.8% in the 4th quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock worth $3,396,132,000 after acquiring an additional 224,122 shares during the period. Dodge & Cox lifted its position in shares of Cigna Group by 19.7% in the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after acquiring an additional 1,833,389 shares during the period. GQG Partners LLC grew its holdings in shares of Cigna Group by 14.3% during the 4th quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock worth $2,136,699,000 after purchasing an additional 972,302 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Cigna Group by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 6,051,370 shares of the health services provider’s stock valued at $1,658,055,000 after purchasing an additional 48,474 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Robert W. Baird set a $362.00 target price on Cigna Group in a research report on Friday, July 31st. Barclays boosted their price target on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. UBS Group increased their price objective on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. Piper Sandler reduced their price objective on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a report on Wednesday, June 3rd. Finally, Wells Fargo & Company lifted their target price on shares of Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $339.45.

Insider Activity

In related news, insider Nicole S. Jones sold 19,436 shares of Cigna Group stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 23,012 shares of company stock valued at $6,386,550 over the last three months. 0.60% of the stock is currently owned by insiders.

Cigna Group Price Performance

Shares of CI stock opened at $278.89 on Friday. The stock’s fifty day simple moving average is $283.52 and its 200 day simple moving average is $281.39. Cigna Group has a one year low of $239.51 and a one year high of $315.47. The firm has a market cap of $73.69 billion, a price-to-earnings ratio of 11.54, a P/E/G ratio of 0.96 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the prior year, the company posted $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts expect that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is 25.82%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.